|
|
|
Insider
Information: |
Hamill John P. |
Relationship: |
SrVP/CFO/Prin Fin & Ac... |
City: |
Madison |
State: |
WI |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
173,902 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$44,825 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
173,902 |
|
|
Total
Value |
$44,825 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
4
|
0
|
|
|
|
Gain/Loss Ratio : |
-4.0
|
0.0
|
Percentage
Gain/Loss : |
-44.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Trevena Inc |
TRVN |
VP Fin,Princ Fin&Acct ... |
2019-06-03 |
82,234 |
2018-12-06 |
0 |
Premium* |
|
Windtree Therapeutics Inc |
WINT |
SVP & CFO |
2022-07-26 |
72,800 |
2020-10-07 |
0 |
Premium* |
|
Aprea Therapeutics, Inc. |
APRE |
SrVP/CFO/Prin Fin & Ac... |
2024-03-28 |
18,868 |
2023-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TRVN |
Trevena Inc |
VP Fin,Princ Fin&Acct Officer |
|
2019-06-03 |
4 |
D |
$1.17 |
$6,454 |
D/D |
(5,516) |
82,234 |
0 |
- |
|
TRVN |
Trevena Inc |
VP Fin,Princ Fin&Acct Officer |
|
2019-05-31 |
4 |
B |
$1.16 |
$8,700 |
D/D |
7,500 |
87,750 |
2.74 |
- |
|
WINT |
Windtree Therapeutics Inc |
SVP & CFO |
|
2020-10-07 |
4 |
B |
$5.27 |
$5,270 |
D/D |
1,000 |
1,000 |
2.74 |
% |
|
WINT |
Windtree Therapeutics Inc |
SVP & CFO |
|
2021-03-25 |
4 |
B |
$3.25 |
$4,875 |
D/D |
1,500 |
2,500 |
2.66 |
% |
|
WINT |
Windtree Therapeutics Inc |
SVP & CFO |
|
2021-04-16 |
4 |
B |
$2.07 |
$2,067 |
D/D |
1,000 |
3,500 |
2.66 |
% |
|
WINT |
Windtree Therapeutics Inc |
SVP & CFO |
|
2022-07-26 |
4 |
B |
$0.37 |
$1,100 |
D/D |
3,000 |
72,800 |
2.66 |
% |
|
APRE |
Aprea Therapeutics, Inc. |
SrVP/CFO/Prin Fin & Acct Ofcr |
|
2024-03-13 |
4 |
B |
$7.29 |
$7,363 |
D/D |
1,010 |
15,503 |
2.74 |
- |
|
TRVN |
Trevena Inc |
VP Fin,Princ Fin&Acct Officer |
|
2018-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
80,250 |
0 |
- |
|
WINT |
Windtree Therapeutics Inc |
SVP & CFO |
|
2022-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
66,300 |
69,800 |
0 |
- |
|
APRE |
Aprea Therapeutics, Inc. |
SrVP/CFO/Prin. Fin&Acctg. Off |
|
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
269,879 |
269,879 |
0 |
- |
|
APRE |
Aprea Therapeutics, Inc. |
SrVP/CFO/Prin Fin & Acct Ofcr |
|
2023-02-27 |
4 |
A |
$5.25 |
$5,250 |
D/D |
1,000 |
14,493 |
0 |
- |
|
APRE |
Aprea Therapeutics, Inc. |
SrVP/CFO/Prin Fin & Acct Ofcr |
|
2024-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,365 |
18,868 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|